AR016308A1 - USE OF PHOSPHODIESTERASE 4 INHIBITORS OR THEIR SALTS, MEDICATION FOR THE TREATMENT OF ALLERGY RHINITIS CONTAINING THE MENTIONED COMPOUNDS AND PROCEDURE TO PREPARE SUCH MEDICINAL PRODUCT. - Google Patents

USE OF PHOSPHODIESTERASE 4 INHIBITORS OR THEIR SALTS, MEDICATION FOR THE TREATMENT OF ALLERGY RHINITIS CONTAINING THE MENTIONED COMPOUNDS AND PROCEDURE TO PREPARE SUCH MEDICINAL PRODUCT.

Info

Publication number
AR016308A1
AR016308A1 ARP980103241A ARP980103241A AR016308A1 AR 016308 A1 AR016308 A1 AR 016308A1 AR P980103241 A ARP980103241 A AR P980103241A AR P980103241 A ARP980103241 A AR P980103241A AR 016308 A1 AR016308 A1 AR 016308A1
Authority
AR
Argentina
Prior art keywords
medication
procedure
phosphodiesterase
inhibitors
salts
Prior art date
Application number
ARP980103241A
Other languages
Spanish (es)
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of AR016308A1 publication Critical patent/AR016308A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de inhibidores de la fosfodiesterasa 4 o sus sales, medicamento para el tratamiento de la rinitis alérgica que contiene los compuestos mencionadosy procedimiento para preparar dicho medicamento. Dicho procedimiento provee un medicamento altamenteefectivo para la terapia de los síntomas de la rinitisalérgica que permite influenciar la infiltracion de la mucosa nasal con granulocitos eosinofilos. Los efectos colaterales de este medicamento son reducidosy permiten una administracion tanto local como sistémica.Use of phosphodiesterase 4 inhibitors or their salts, medicament for the treatment of allergic rhinitis containing the aforementioned compounds and procedure for preparing said medication. This procedure provides a highly effective medication for the therapy of rhinitisallergic symptoms that allows to influence the infiltration of the nasal mucosa with eosinophilic granulocytes. The side effects of this medication are reduced and allow both local and systemic administration.

ARP980103241A 1997-07-03 1998-07-03 USE OF PHOSPHODIESTERASE 4 INHIBITORS OR THEIR SALTS, MEDICATION FOR THE TREATMENT OF ALLERGY RHINITIS CONTAINING THE MENTIONED COMPOUNDS AND PROCEDURE TO PREPARE SUCH MEDICINAL PRODUCT. AR016308A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19728301A DE19728301A1 (en) 1997-07-03 1997-07-03 Use of inhibitors of phosphodiesterase 4 for the treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
AR016308A1 true AR016308A1 (en) 2001-07-04

Family

ID=7834441

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103241A AR016308A1 (en) 1997-07-03 1998-07-03 USE OF PHOSPHODIESTERASE 4 INHIBITORS OR THEIR SALTS, MEDICATION FOR THE TREATMENT OF ALLERGY RHINITIS CONTAINING THE MENTIONED COMPOUNDS AND PROCEDURE TO PREPARE SUCH MEDICINAL PRODUCT.

Country Status (6)

Country Link
AR (1) AR016308A1 (en)
AU (1) AU8626398A (en)
CA (1) CA2241879A1 (en)
DE (1) DE19728301A1 (en)
WO (1) WO1999001134A1 (en)
ZA (1) ZA985481B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
DE10012373A1 (en) * 2000-03-14 2001-09-20 Dresden Arzneimittel Treating erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, as cGMP-selective phosphodiesterase V inhibitors free of cardiovascular side-effects
CN113016634B (en) * 2021-04-16 2023-07-21 安徽省农业科学院农产品加工研究所 Method for preparing urethra-protecting cat litter by utilizing mixed fermentation of probiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases

Also Published As

Publication number Publication date
AU8626398A (en) 1999-01-25
CA2241879A1 (en) 1999-01-03
WO1999001134A1 (en) 1999-01-14
ZA985481B (en) 1998-08-25
DE19728301A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
CO4340681A1 (en) USE PROCEDURES FOR THE INHIBITION OF LOSS OF OSEA AND THE DECREASE OF CHOLESTEROL IN SERUM
CO5011096A1 (en) MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS
ES2062392T3 (en) MEDICATIONS INCLUDING SALMETEROL AND FLUTICASONE.
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
MX9301929A (en) DERIVATIVES OF PIRIMIDINE AND PROCEDURES FOR ITS PREPARATION.
ES2139132T3 (en) PHARMACEUTICAL COMPOSITIONS ACTIVE IN SLEEP DISORDERS THERAPY.
AR005282A1 (en) ORAL PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET OF MULTIPLE UNITS, USE OF THE SAME FOR THE PREPARATION OF MEDICINES, AND PROCEDURE FOR ITS MANUFACTURE.
ATE444768T1 (en) DRUG DELIVERY SYSTEMS
ES2113444T3 (en) MEDICINES.
AR037255A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING OXIBUTININE
CR7362A (en) PHARMACEUTICAL FORMULATIONS OF PLATINUM DERIVATIVE
ES2080307T3 (en) PHARMACEUTICAL COMPOSITIONS.
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
MX9307885A (en) APPLICATION OF CARBAMZAEPINE AND OXCARBAZEPIAN TO OBTAIN MEDICINES FOR THE TREATMENT OF PARKINSON DISEASE AND PARKINSONIAN SYNDROMES.
BR0115162A (en) Effective antitumor treatments
HN2000000050A (en) MUTUAL SALT OF AMLODIPINO AND ATORVASTATINA
CO5700723A2 (en) USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY
ITBO930205A1 (en) USE OF SULODEXIDE AND OF THE MEDICINAL SPECIALTIES THAT CONTAIN IT IN THE TREATMENT OF DIABETIC NEPHROPATHY.
CO4940448A1 (en) GLASS MODIFICATION OF A MEDICINAL SUBSTANCE
BR0109893A (en) Pharmaceutical preparation of lerisetron in the form of a transdermal therapeutic system, use of the preparation, use of the active substance lerisetron and method for administering the active substance lerisetron to a patient
ES2094834T3 (en) DEVICE FOR WASHING, FOR THERAPEUTIC OR HYGIENE PURPOSES, OF INTERNAL HUMAN OR ANIMAL DUCTS.
AR029588A1 (en) NEW FORM (R) -N- [5-METHYL-8- (4-METHYLIPIPERAZINE-1-IL) -1,2,3,4-TETRAHYDRO-2-NAFTIL] -4-MORFOLINOBENZAMIDA
AR016308A1 (en) USE OF PHOSPHODIESTERASE 4 INHIBITORS OR THEIR SALTS, MEDICATION FOR THE TREATMENT OF ALLERGY RHINITIS CONTAINING THE MENTIONED COMPOUNDS AND PROCEDURE TO PREPARE SUCH MEDICINAL PRODUCT.
DE59914183D1 (en) DISPOSABLE DEVICE FOR A COMPOSITION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.